BG
ETNB

Bellevue Group’s 89bio ETNB Stock Holding History

Bellevue Group’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-24,700
Closed -$198K – 170
2024
Q2 		$198K Buy
24,700
+11,000
+80% +$98.2K ﹤0.01% 148
2024
Q1 		$159K Sell
13,700
-6,500
-32% -$72K ﹤0.01% 157
2023
Q4 		$226K Sell
20,200
-19,000
-48% -$175K ﹤0.01% 148
2023
Q3 		$605K Sell
39,200
-26,000
-40% -$436K 0.01% 139
2023
Q2 		$1.24M Sell
65,200
-1,800
-3% -$31.6K 0.02% 124
2023
Q1 		$1.02M Buy
+67,000
New +$874K 0.01% 128

Other funds holding ETNB

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Bellevue Group's ETNB Position: Q3 2024 in Review

Bellevue Group sold out of 89bio (ETNB) in Q3 2024, closing a stake of 24,700 shares — an estimated $198K sold.

Bellevue Group first reported a position in ETNB in Q1 2023 and held it in 6 quarters. The position peaked at $1.24M in Q2 2023. 144 funds tracked by Wall St. Rank hold ETNB as of Q3 2024.

  • Bellevue Group reported no remaining 89bio position as of Q3 2024 after selling out during the quarter.
  • Bellevue Group sold 24,700 89bio shares in Q3 2024, an estimated $198K.
  • Bellevue Group first reported a position in 89bio in Q1 2023 and held it in 6 quarters.
  • Bellevue Group's 89bio position peaked at $1.24M in Q2 2023.
  • 144 funds tracked by Wall St. Rank held 89bio as of Q3 2024.

Based on Bellevue Group's 13F filing for Q3 2024, filed 14 Nov 2024.